Quest Diagnostics has elected Jeffrey Leiden to its Board of Directors. Leiden is the chairman, president, and CEO of Vertex Pharmaceuticals. Prior to that, he was a managing director at Clarus Ventures, and before that served as president, chief operating officer, and chief scientific officer at Abbott Laboratories. He has more than 20 years of scientific and commercial experience in the pharmaceutical and biotechnology industries as well as clinical and scientific experience as a cardiologist and molecular biologist.
Nabsys said that Anthony Shuber has joined the company as VP and chief scientific officer. He joins the firm from Ignyta, an oncology precision medicine firm, where he served as chief technology officer. Prior to joining Ignyta, Shuber was co-founder and CTO of Predictive Biosciences, and scientific co-founder of Exact Sciences. He also previously worked for Genzyme Genetics/Integrated Genetics and Genetics Institute.